Latest news
Amgen Details Phase 3 Sleep Apnea Studies for Investigational Drug MariTide - Sleep ReviewSleep Review · Wed, 05 Aug 2026 19:43:36 GMTAmgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 20:23:55 GMTAmgen Weight Loss Drug: MariTide Phase 2 Results, Benefits, and Practical Insights *VZeiT6rHa* - Diario ASDiario AS · Mon, 03 Aug 2026 10:36:47 GMT